KP Tissue Inc.
TSX:KPT.TOHousehold & Personal Products
-$0.04 today
- Market cap
- $123.80M
- Beta
- 0.42
- P/E (TTM)
- 33.9
- EPS (TTM)
- $0.39
- Dividend yield
- 5.46%
Volume 0.01M
Average 0.02M
KPT.TO Other Working Capital
Cash effect of changes in other operating assets and liabilities.
KP Tissue Inc.TSX: KPT.TO
Other Working Capital · Q2 FY2025 · quarter ended Jun 2025
Other working capital turns positive
Q2 FY2025 other working capital was CA$0, compared with -CA$200K a year earlier. Trailing-twelve-month other working capital was CA$65K. Over 3 fiscal years it compounded at -31.3% a year.
Context
- Other working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other working capital holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$16.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
CAD · from the cash flow
- Latest · FY2024
- (595K) CAD
- Year-over-year change
- —
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2024 | 2024-12-31 | (595K) | — |
| FY2023 | 2023-12-31 | 0 | +100.0% |
| FY2022 | 2022-12-31 | (76K) | +95.9% |
| FY2021 | 2021-12-31 | (1.84M) | -152.3% |
| FY2020 | 2020-12-31 | (728K) | — |
Other Working Capital vs competitors
How KPT.TO compares with its peers on the latest reported figures
- KPT.TO's LTM Jun 2025 other working capital of CA$65K is the smallest of the 2 companies compared; the peer median is CA$14.72M.
- Its year-over-year change of -53.6% is the lowest of 2, against a peer median of +219.6%.
- Over three fiscal years its annual growth of -31.3% compares with a peer median of +10.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$14.72M | +219.6% | +10.1% | 5.8% | |
| LTM Jun 2025 | CA$65K | -53.6% | -31.3% | — | |
| Peer median (excluding KPT.TO) | CA$14.72M | +219.6% | +10.1% | 5.8% | |
Competitors are the stored peer set for KPT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Net Income | (1.95M) | 1.24M | (10.25M) | 1.96M | 2.43M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | (1.42M) | (2.21M) | (1.89M) | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 146K | 233K | (76K) | 287K | (595K) |
| Accounts Receivables | 874K | 2.07M | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 287K | 0 |
| Other Working Capital | (728K) | (1.84M) | (76K) | 0 | (595K) |
| Other Non-Cash Items | 786K | 1.89M | 18.83M | 4.73M | (1.84M) |
| Operating Cash Flow | (2.44M) | 1.15M | 6.62M | 6.98M | 6.97M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 5.6M | 5.56M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 5.56M | 6.62M | 6.98M | 6.97M |
| Investing Cash Flow | 5.6M | 5.56M | 6.62M | 6.98M | 6.97M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.6M) | (5.56M) | (6.62M) | (6.98M) | (6.97M) |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | (5.6M) | (5.56M) | (6.62M) | (6.98M) | (6.97M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (2.44M) | 1.15M | 6.62M | 6.98M | 0 |
| Free Cash Flow | (2.44M) | 1.15M | 6.62M | 6.98M | 6.97M |
KP Tissue Inc.
TSX:KPT.TO
Intrinsic Alpha fair value
Locked
Current Price
$12.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.